- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,130GBP
- Report
- November 2021
- 600 Pages
Global
From €3778EUR$4,000USD£3,215GBP
Ziconotide is a non-opioid analgesic drug used to treat severe chronic pain. It is a synthetic peptide derived from the venom of the Conus magus snail, and is the first and only approved member of the class of drugs known as conotoxins. Ziconotide is administered intrathecally, meaning it is injected directly into the cerebrospinal fluid surrounding the spinal cord. It works by blocking the transmission of pain signals from the nerves to the brain.
Ziconotide is approved for use in adults who have not responded to other treatments for severe chronic pain. It is typically used as a last resort for patients who have not responded to other treatments, such as opioids, non-steroidal anti-inflammatory drugs, and anticonvulsants.
The ziconotide market is a niche market, with few competitors. Companies in the market include Acorda Therapeutics, Inc., Depomed, Inc., and Mallinckrodt Pharmaceuticals. Show Less Read more